Neural Concept and OPmobility Announce Partnership and Demonstrate New AI-Driven Designs for Hybrid, Hydrogen and Complete Vehicles Bodies at CES 2025 January 7, 2025
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis November 29, 2024
New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™) October 21, 2024
French Companies Demonstrate Strong Commitment to Driving India’s growth at the 47th AGM of the Indo-French Chamber of Commerce & Industry (IFCCI) September 28, 2024
